To further confirm the expression patterns of Galectin-3 in thyroid cancer, we conducted immunohistochemistry in 20 surgical specimens, including 19 pathology-confirmed papillary thyroid cancer samples and 1 anaplastic cancer sample. The gene discussed is LGALS3; the disease is thyroid gland carcinoma.